Gene Transfer in Transplantation

Abstract

The introduction of genetic information into tissues or organs to be transplanted aims to confer new biological properties on the grafts. Gene transfer has already shed light on the basic mechanisms of graft rejection and tolerance, and has the potential to be applied in the clinic.

Keywords: transplantation; gene therapy; transgenesis; inflammation; cytokines; costimulation

Figure 1.

Gene transfer strategies in transplantation.

close

References

Amersi F, Buelow R, Kato H, et al. (1999) Upregulation of heme oxygenase‐1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury [see comments]. Journal of Clinical Investigation 104: 1631–1639.

Barkats M, Nakao N, Grasbon‐Frodl EM, et al. (1997) Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase. Neuroscience 78: 703–713.

Bilbao G, Contreras JL, Gomez‐Navarro J, et al. (1999) Genetic modification of liver grafts with an adenoviral vector encoding the Bcl‐2 gene improves organ preservation. Transplantation 67: 775–783.

DeBruyne LA, Li K, Bishop DK and Bromberg JS (2000) Gene transfer of virally encoded chemokine antagonists vMIP‐II and MC148 prolongs cardiac allograft survival and inhibits donor‐specific immunity. Gene Therapy 7: 575–582.

Emery DW, Sablinski T, Shimada H, et al. (1997) Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity. Transplantation 64: 1414–1423.

Guillot C, Mathieu P, Coathalem H, et al. (2000) Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus‐mediated CTLA4Ig expression. Journal of Immunology 164: 5258–5268.

Guillot C, Ménoret S, Guillonneau C, et al. (2003) Active suppression of allogeneic proliferative responses by dendritic cells after induction of long term allograft survival by CTLA4Ig. Blood 101(8): 3325–3333.

Josien R, Douillard P, Guillot C, et al. (1998) A critical role for transforming growth factor‐β (TGF‐β) in donor transfusion‐induced allograft tolerance. Journal of Clinical Investigation 102: 1920–1926.

Knechtle SJ, Wang J, Graeb C, et al. (1997) Direct MHC class I complementary DNA transfer to thymus induces donor‐specific unresponsiveness, which involves multiple immunologic mechanisms. Journal of Immunology 159: 152–158.

Madsen JC, Superina RA, Wood KJ and Morris PJ (1988) Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332: 161–164.

Mathieu P, Guillot C, Chauveau C, et al. (2002) Genetic engineering in allotransplantation of vascularized organs. Current Gene Therapy 2: 9–21.

Min WP, Gorczynski R, Huang XY, et al. (2000) Dendritic cells genetically engineered to express Fas ligand induce donor‐specific hyporesponsiveness and prolong allograft survival. Journal of Immunology 164: 161–167.

Platt JL and Logan JS (1996) Use of transgenic animals in xenotransplantation. Transplantation Review 10: 69–97.

Qin L, Chavin KD, Ding Y, et al. (1996) Retrovirus‐mediated transfer of viral IL‐10 gene prolongs murine cardiac allograft survival. Journal of Immunology 156: 2316–2323.

Further Reading

Asahara T, Kalka C and Isner JM (2000) Stem cell therapy and gene transfer for regeneration. Gene Therapy 7: 451–457.

Bach F, Hancock W and Ferran C (1997) Protective genes expressed in endothelial cells: a regulatory response to injury. Immunology Today 18: 483–486.

Bluestone JA (1996) Costimulation and its role in organ transplantation. Clinical Transplantation 10: 104–109.

Cohen JL, Boyer O and Klatzmann D (1999) Would suicide gene therapy solve the T‐cell dilemma of allogeneic bone marrow transplantation? Immunology Today 20: 172–176.

Cuturi MC, Blancho G, Josien R and Soulillou JP (1994) The biology of allograft rejection. Current Opinion in Nephrology and Hypertension 3: 578–584.

Nickerson P, Steiger J, Xiao Zheng X, et al. (1997) Manipulation of cytokine networks in transplantation. False hope or realistic opportunity for tolerance. Transplantation 63: 489–494.

Waldmann H (1999) Transplantation tolerance – where do we stand? Nature Medicine 5: 1245–1248.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Anegon, Ignacio(Jan 2006) Gene Transfer in Transplantation. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0005760]